Retrospective Analysis Of Progression Free Survival And Overall Survival In A National Cohort Of Patients With Metastatic Renal Cell Carcinoma Treated In Denmark From 2006-2010. DARENCA Study 2.

CompletedOBSERVATIONAL
Enrollment

1,073

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Renal Cell Carcinoma
Interventions
OTHER

Non-interventional

Non-interventional (retrospective chart reviews)

Trial Locations (1)

2730

University of Copenhagen Herlev Hospital, Herlev

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Copenhagen University Hospital at Herlev

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Aarhus University Hospital

OTHER

collaborator

Odense University Hospital

OTHER

collaborator

Danish Renal Cancer Study Group

NETWORK

lead

Pfizer

INDUSTRY